Skip to main content

Department of Pediatrics

Discovery may point to better treatments for Type 1 diabetes

Aug. 22, 2019—Researchers have made a paradigm-shifting discovery that could lead to new treatments, better health and longer life for patients with Type 1 diabetes.

Read more


Host-microbe interactions in the gut

Aug. 13, 2019—Vanderbilt investigators demonstrated that intestinal cells promote beneficial microbe behavior — the findings support developing microbiota-based therapies for intestinal health.

Read more


Benzodiazepine use with opioids intensifies neonatal abstinence syndrome

Jul. 1, 2019—Babies born after being exposed to both opioids and benzodiazepines before birth are more likely to have severe drug withdrawal, requiring medications like morphine for treatment, compared to infants exposed to opioids alone.

Read more


Cell-cell signals in developing heart

Jun. 10, 2019—Scott Baldwin and colleagues have discovered early signaling events during heart development, findings that could guide cell replacement therapies for heart disease.

Read more


Treating core Rett syndrome symptoms

Jun. 6, 2019—A new study published in Neurology reports the drug trofinetide has proven safe and effective in treating core symptoms of Rett syndrome in female children and adolescents.

Read more


Keeping bone in its place

Apr. 12, 2019—Jonathan Schoenecker, Stephanie Moore-Lotridge and colleagues have found a new target for treating a condition that causes bone to form in soft tissue, reducing mobility.

Read more


In utero antibiotics and obesity risk

Jan. 31, 2019—Exposure to antibiotics during pregnancy does not raise the risk of obesity in children.

Read more


Long-term unemployment linked to increase in babies born with drug withdrawal

Jan. 30, 2019—Babies born with neonatal abstinence syndrome are more likely to be delivered in regions of the U.S. with high rates of long-term unemployment and lower levels of mental health services.

Read more


VUMC scientists ‘sprint’ to find anti-Zika antibodies

Jan. 25, 2019—Scientists at Vanderbilt University Medical Center and colleagues in Boston, Seattle and St. Louis are racing to develop — in a mere 90 days — a protective antibody-based treatment that can stop the spread of the Zika virus.

Read more


Study links soy formula feeding and menstrual pain

Dec. 13, 2018—The report authored by Margaret Adgent adds to the increasing evidence supporting the reproductive health consequences of early-life exposure to soy formula.

Read more


Team isolates antibodies that neutralize GI bug norovirus

Aug. 30, 2018—The discovery of these antibodies could significantly improve the diagnosis and treatment of the leading cause of stomach illness in the world.

Read more


Risk factors for faulty rhythms

Aug. 17, 2018—Prince Kannankeril and colleagues explored clinical and genetic factors associated with atrial tachycardia after congenital heart disease surgery in infants younger than 1 year old.

Read more


VIEW MORE EVENTS >